Real-world healthcare resource utilization of Alzheimer’s disease in the early and advanced stages: a retrospective cohort study
Although all-cause HCRU was similar, patients with advanced AD incurred higher AD-related HCRU compared to patients living with early AD. Further research is needed to determine whether interventions earlier in disease progression can mitigate the AD-related healthcare burden for patients with advanced AD.
Authors
- Chia‐Lun Liu (ORCID: https://orcid.org/0000-0003-4604-6031)
- Abdalla Aly (ORCID: https://orcid.org/0000-0001-7411-894X)
- Soeren Mattke (ORCID: https://orcid.org/0000-0003-4666-9132)
- Raj Desai (ORCID: https://orcid.org/0000-0003-3010-820X)
- Marianne Cunnington (ORCID: https://orcid.org/0009-0002-2398-2281)
- Mei Sheng Duh (ORCID: https://orcid.org/0000-0001-5035-6687)
- Elnara Fazio‐Eynullayeva (ORCID: https://orcid.org/0000-0002-0594-0275)
- Christopher Yee (ORCID: https://orcid.org/0009-0006-9269-7416)
- Lei Lv (ORCID: https://orcid.org/0009-0008-1160-0673)
- Paul Mystkowski
Institutions
- University of Southern California (US)
- Southern California University of Health Sciences (US)
- Novo Nordisk (United States) (US)
- Novo Nordisk (United Kingdom) (GB)
- Institute of Group Analysis (GB)
- Analysis Group (United States) (US)
Publication Details
- Journal
- Journal of Medical Economics
- Published
- 2024-12-13
- DOI
- https://doi.org/10.1080/13696998.2024.2442240
- Citations
- 3
- Primary Topic
- Dementia and Cognitive Impairment Research
- Type
- article
- Field-Weighted Citation Impact
- 1.16